Extivita Proposes Minimize Loss of Life From COVID-19 with HBOT
Hyperbaric Oxygen Therapy (HBOT) can destroy harmful bacteria and viruses, while enhancing the body’s natural defenses. We propose HBOT for high risk, early stage COVID-19 patients, recommending this novel use of pressure and oxygen based on its low risk and...Emergency Hyperbaric Oxygen for Respiratory Distress or Failure for COVID-19 Patients
April 2, 2020, Dr. David Lee posted a new clinical trial on the NIH Clinical Trials website to study the use of Hyperbaric Oxygen Therapy (HBOT) to treat COVID-10. The study is listed as “Not Recruiting Yet,” but has an estimated completion date of July...Hyperbaric oxygen therapy in the treatment of COVID-19 — severe cases
From Wuhan China — promising results have just been published by Dr. Zhong Yangling for the treatment of 5 COVID-19 patients (2 of which were critical and 3 were severe) with hyperbaric therapy at the Department of Hyperbaric Oxygen in Wuhan Yangtze River Shipping...Clinical Trial – Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19
COVID-19 may cause severe pneumonitis that require ventilatory support in some patients, the ICU mortality is as high as 62%. Hospitals do not have enough ICU beds to handle the demand and to date there is no effective cure. We explore a treatment administered in a randomized clinical trial that could prevent ICU admission and reduce mortality. The overall hypothesis to be evaluated is that HBO reduce mortality, increase hypoxia tolerance and prevent organ failure in patients with COVID19 pneumonitis by attenuating the inflammatory response.